Social Wire
Tweeted
Dec 4, 2025
Prenetics
@Prenetics Our hearts are with Tai Po. We’re donating HK$500,000 to the “Support Fund for Wang Fuk Court in Tai Po”. We stand in solidarity with our community, extend our deepest condolences to all who are grieving, and invite those who can to support relief eff9zcFXp
Prenetics
@Prenetics Our hearts are with Tai Po. We’re donating HK$500,000 to the “Support Fund for Wang Fuk Court in Tai Po”. We stand in solidarity with our community, extend our deepest condolences to all who are grieving, and invite those who can to support relief eff9zcFXp
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 8/8 🧵The plan is simple and measurable: $180–200M FY-2026, and a path to $1B ARR by 2030 through focused product extensions and geographic expansion. TL;DR: repeatable product, improving economics, strong runway = real optionality to win.
Prenetics
@Prenetics 8/8 🧵The plan is simple and measurable: $180–200M FY-2026, and a path to $1B ARR by 2030 through focused product extensions and geographic expansion. TL;DR: repeatable product, improving economics, strong runway = real optionality to win.
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 7/8 🧵 We’re global by design: 420K+ customer purchases across 41 countries, with 56.5% of revenue outside the U.S. Add David Beckham as co-founder, Aryna Sabalenka’s authentic partnership and investment, a world-class scientific advisory board, and an unconventional Bitcoin
Prenetics
@Prenetics 7/8 🧵 We’re global by design: 420K+ customer purchases across 41 countries, with 56.5% of revenue outside the U.S. Add David Beckham as co-founder, Aryna Sabalenka’s authentic partnership and investment, a world-class scientific advisory board, and an unconventional Bitcoin
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 6/8 🧵 Scale needs runway. We have it: $82M cash + 387 BTC (~$40M) ≈ $122M liquid assets, zero debt, and the $44M October raise. That balance sheet gives optionality to invest aggressively while competitors get cautious.
Prenetics
@Prenetics 6/8 🧵 Scale needs runway. We have it: $82M cash + 387 BTC (~$40M) ≈ $122M liquid assets, zero debt, and the $44M October raise. That balance sheet gives optionality to invest aggressively while competitors get cautious.
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 5/8 🧵 The unit economics tell the compounding story: ~80% subscription, ~60% gross margin, 3.9-month payback. Adjusted EBITDA moved from roughly $6M (Q1) → $4M (Q2) → $2.1M (Q3), improving fast while we scale. That’s why we can afford to double down.
Prenetics
@Prenetics 5/8 🧵 The unit economics tell the compounding story: ~80% subscription, ~60% gross margin, 3.9-month payback. Adjusted EBITDA moved from roughly $6M (Q1) → $4M (Q2) → $2.1M (Q3), improving fast while we scale. That’s why we can afford to double down.
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 4/8 🧵 The growth was healthy and broad. Q3 ended with $6.6M monthly revenue, $17.2M quarterly revenue, 160K+ orders, and 4.8M+ servings delivered. Synchronized gains across acquisition, delivery, and repeat use, not a one channel spike.
Prenetics
@Prenetics 4/8 🧵 The growth was healthy and broad. Q3 ended with $6.6M monthly revenue, $17.2M quarterly revenue, 160K+ orders, and 4.8M+ servings delivered. Synchronized gains across acquisition, delivery, and repeat use, not a one channel spike.
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 3/8 🧵We built momentum off a single, obsessively-refined SKU: Daily Ultimate Essentials. That discipline paid off when Daily Ultimate Longevity launched in October and customers began upgrading: AOV climbed to $150. Product quality created the pull
Prenetics
@Prenetics 3/8 🧵We built momentum off a single, obsessively-refined SKU: Daily Ultimate Essentials. That discipline paid off when Daily Ultimate Longevity launched in October and customers began upgrading: AOV climbed to $150. Product quality created the pull
Tweeted
Nov 10, 2025
Prenetics
@Prenetics 2/8 🧵 Three levers powered the ramp: • Product rigor: clinical testing, NSF third-party verification and an obsessive focus on formulation gave customers confidence • Subscription-first economics: high subscription rates and rising AOV created predictable, compounding revenue
Prenetics
@Prenetics 2/8 🧵 Three levers powered the ramp: • Product rigor: clinical testing, NSF third-party verification and an obsessive focus on formulation gave customers confidence • Subscription-first economics: high subscription rates and rising AOV created predictable, compounding revenue